Friday, January 11, 2008

Practice for Evaluation and Management of Female Urinary Tract Infection

Reasoning and EBP Investigation


Recommended EBP guidelines for discussion of UTI in this sex and age grouping were partially followed in the case natural event.
Bactrim DS one cake, twice daily for 3 days, is the most frequently recommended antibiotic programme for treating uncomplicated, lower UTI (Guidelines Advisory NGO [GAC], 2003; Katchman et al., 2004; NGC, 2000; Uphold & Revivalist, 2003).
Antibiotic regimes of just 1 day have been associated with high skip rates and those greater than 3 days have been deemed unnecessary in this settlement (Delzell & Fitzsimmons, 2005; NGC, 2000).
When Bactrim DS is contraindicated, as with an allergy or electric resistance, the recommended second-line artistic style is with a quinolone drug for 3 days (GAC, 2003; NGC, 2000).
Examples of quinolones include CiproAE (ciprofloxacin) 250 mg twice daily for 3 days, or LevaquinAE (levofloxacin) 250 mg, once daily for 3 days.
Finally, if the above recommendations are contraindicated, another derivative is for 7 days of MacrobidAE (nitrofurantoin), AmoxilAE (amoxicillin), or a first-generation cephalosporin such as KeflexAE (cephalexin) (GAC, 2003; NGC, 2000).

Signs and symptoms usually written document within 2 to 3 days of antibiotic management.
Vesica analgesics such as PyridiumAE (phenazopyridine) are ill advised due to the choice of aesthesis signs or symptoms of complications such as pyelonephritis, renal abscess, or urinary vent physical condition (Delzell & Fitzsimmons, 2005).
One deviation in the case lesson and the published GAC and UMHS guidelines is with the piece of work engagement.
Pub lished guidelines suggest that no examination stay is necessary if symptoms papers in 3 days and that a urine refinement is only indicated when symptoms persists or do not subside within 3 days (GAC, 2003; UMHS, 1999).

Women ages 18 to 64, and particularly those on the younger end of that reach, have a unique risk of experiencing decreased oral contraceptive efficacy (if applicable) when simultaneously taking an antibiotic.
Care is advised as the antibiotic competes for sites with the oral contraceptive, thereby decreasing its efficacy.
In the case good example, a electric potential fundamental interaction between Mircette and Bactrim DS may occur.
EBP guidelines suggest use of an alternative antibiotic such as a tetracycline drug or ampicillin (enterohepatic recirculation altered) (Epocrates, 2004).
This is a part of article Practice for Evaluation and Management of Female Urinary Tract Infection Taken from "Bactrim Information" Information Blog

No comments: